TONIX PHARMACEUTICALS HOLDING CORP. Debt Instrument, Face Amount
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Debt Instrument, Face Amount of $300.00 thousand as of 2013-08-01, per its 10-K filed 2016-03-03.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2016-03-03
- 2013-08-01: Debt Instrument, Face Amount $300.00K.
- 2013-07-31: Debt Instrument, Face Amount $300.00K.
- 2012-11-14: Debt Instrument, Face Amount $390.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2013-08-01 | $300.00K 10-K · filed 2016-03-03 |
| 2013-07-31 | $300.00K 10-K · filed 2016-03-03 |
| 2012-11-14 | $390.00K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |